--- title: "Assessing Intrum (OM:INTRUM) Valuation After Quarterly Net Loss And SEK6b Rights Issue" type: "News" locale: "en" url: "https://longbridge.com/en/news/285837141.md" description: "Intrum (OM:INTRUM) has reported a quarterly net loss and announced a SEK 6b rights issue, leading to a significant drop in share prices (-13.85% in one day, -34.70% over seven days). The stock is currently trading at a steep discount to analyst price targets, with a fair value estimated at SEK 47.17 per share compared to its last close of SEK 23.26. Despite concerns over high net debt and potential write-downs, there is a narrative suggesting the stock may be undervalued, prompting investors to consider broader market opportunities." datetime: "2026-05-10T10:00:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285837141.md) - [en](https://longbridge.com/en/news/285837141.md) - [zh-HK](https://longbridge.com/zh-HK/news/285837141.md) --- # Assessing Intrum (OM:INTRUM) Valuation After Quarterly Net Loss And SEK6b Rights Issue Intrum (OM:INTRUM) has drawn fresh attention after reporting a quarterly net loss and filing a SEK 6b rights offering, a combination that raises clear questions about earnings quality and balance sheet resilience. See our latest analysis for Intrum. The sharp 1-day share price return of -13.85% and 7-day share price return of -34.70% suggest investors are rapidly repricing Intrum after the quarterly net loss and the planned SEK 6b rights issue. At the same time, the 1-year total shareholder return of -37.97% and 5-year total shareholder return of -89.80% indicate that longer term momentum has been weak. If this kind of repricing has you looking beyond a single stock, it could be a useful moment to scan the market for other ideas through a 99 top founder-led companies With Intrum posting a quarterly net loss, planning a SEK 6b rights issue and trading at a steep discount to analyst price targets, you have to ask if this punished stock is now undervalued or if markets are already pricing in future growth. ## Most Popular Narrative: 50.7% Undervalued Intrum's most followed narrative anchors fair value at SEK47.17 per share, compared with the last close of SEK23.26. This frames the recent sell off against a much higher long term earnings outlook. > _Disciplined but rising investment volumes in the portfolio business, underpinned by performance above original collection curves and strong IRRs, can stabilize the shrinking book and eventually return investing income and cash EBITDA to growth._ _Read the complete narrative._ Want to see how flat revenue, rising margins and a future earnings rebuild combine to support that valuation gap? The full narrative spells out the earnings bridge, the assumed profitability shift and the implied valuation multiple behind that SEK47.17 figure. **Result: Fair Value of SEK47.17 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, this depends on Intrum managing high net debt of about SEK45b and avoiding further write downs after recent goodwill and contract impairments. Find out about the key risks to this Intrum narrative. ## Next Steps With sentiment clearly split between concern and optimism, this is a moment to check the full picture quickly and weigh the 4 key rewards and 2 important warning signs. ## Looking for more investment ideas? If Intrum's sharp moves have your attention, do not stop here. Broader opportunities across the market could be just as important for your next decision. - Target potential mispricings by scanning 231 high quality undervalued stocks with stronger fundamentals than the headline action suggests. - Zero in on reliability by reviewing the solid balance sheet and fundamentals stocks screener (386 results) that might better withstand tough conditions. - Spot early-stage opportunities by checking the 224 elite penny stocks with strong financials that meet stricter quality filters than typical low priced stocks. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Related Stocks - [ITJTY.US](https://longbridge.com/en/quote/ITJTY.US.md) - [ITJTQ.US](https://longbridge.com/en/quote/ITJTQ.US.md) ## Related News & Research - [Intrum Sets January Date to Unveil 2025 Results and Strategic Review](https://longbridge.com/en/news/270177338.md) - [A Look At Skandinaviska Enskilda Banken (OM:SEB A) Valuation After Mixed Recent Share Performance](https://longbridge.com/en/news/285853012.md) - [Outset Medical (OM) Q1 2026 Earnings Transcript](https://longbridge.com/en/news/285627511.md) - [Assessing Bufab (OM:BUFAB) Valuation After Strong Q1 2026 Earnings And Earnings Growth](https://longbridge.com/en/news/285354401.md) - [Is It Too Late To Consider Buying Volvo (OM:VOLV B) After Its Strong Multi Year Run?](https://longbridge.com/en/news/285597401.md)